Los Angeles, CA. August 26, 2021 – US Nuclear Corp . (OTCQB: UCLE), a leading manufacturer of advanced radiation, chemical, and biological detection and UAV instrumentation, recently announced the financial results for the first quarter ended March 31, 2021. Sales for the three months ended March 31, 2021, were $417,824 compared to $322,239 for the same period in 2020, an increase of 29.7% Gross profit was $201,172 compared to $166,327 for the same period in 2020, an increase of 20.9% Selling, general, and administrative expense were $860,151 compared to $894,842 for the same period in 2020, the decrease of $34,691 or 3.9% was due to lower stock-based compensation Stock-based compensation was $378,838 compared to $453,096 during the same period in 2020 Other expense was $4,582, a decrease of $314,272 from $318,854 for the same period in 2020 Net loss of $663,561 Robert Goldstein, CEO of US Nuclear Corp ., commented: “We are happy to announce that our sales revenue is continuing t...